FP MAP protein-free blocker
Fapon Biotech has developed a proprietary protein-free blocker, FP MAP to minimize non-specific interactions in an IVD assay. It would be of great utility to IVD developers. FP MAP, comprising an amphoteric polymer, has hydrophobic and hydrophilic sides in its chemical structure. The hydrophobic side binds to the non-specific protein binding sites on the solid substrate, while the hydrophilic side is exposed to the environment to build a protective hydrophilic layer that prevents the binding of interfering proteins.
Overview
It would be of great utility to IVD developers. FP MAP, comprising an amphoteric polymer, has hydrophobic and hydrophilic sides in its chemical structure. The hydrophobic side binds to the non-specific protein binding sites on the solid substrate, while the hydrophilic side is exposed to the environment to build a protective hydrophilic layer that prevents the binding of interfering proteins.
Benefits
Chemically synthesized, minimal inter-batch variations, non-animal origin
Small molecule blocks much better than larger conventional blockers
Reduced cross-reactivity and non-specific binding
Increased sensitivity
Available for different platforms
High production yield (in kg)
10x concentrated on efficient shipment
Performance
FP MAP's performance in ELISA:
FP MAP's performance in CLIA:
FP MAP is the best in inhibiting non-specific binding on ELISA platform.
FP MAP is the best in inhibiting non-specific binding on CLIA platform.
Join us for a better future of IVD.
If you have any question or need any support, please fill out the information below.
